Bayer Posts Q3 Results
HealthCare again great – wavering house at CropScience – MaterialScience intrinsically improved / Order sales EUR 7,392 million (minus 7.0 percent) / EBITDA before valued items EUR 1,499 million (with an increment of 0.4 percent) / Net proceeds EUR 249 million (minus 10.1 percent) / Net spondulix swirl EUR 1,517 million (advantage 22.9 percent) / Full-year Assort forecast confirmed – In the third shelter, the Bayer Aggregation achieved a snub year-on-year proliferate in underlying earnings for the first duration this year. “We are very thrilled to have reversed the earnings mode without considering the to be sure that many industries are still torment from the cost-effective danger,” said Control Timber Chairman Werner Wenning when the interim piece was published on Tuesday. “We are still adhering to our hopeful full-year prediction for the Bayer Troop,” he added....
